Skip to main content
. 2017 Dec 9;9(1):706–717. doi: 10.18632/oncotarget.23091

Figure 2. Dactolisib enhances the inhibitory effect of TMZ+RT on migration of glioma cells.

Figure 2

(A) Micrographs showing cell migration of A172, SHG44, and T98G cells exposed to dactolisib, TMZ+dactolisib, or TMZ+RT+dactolisib for 24 hours. (B) Quantitative data of cell migration as shown in panel (A) Data are from three independent experiments. *P < 0.05 vs. control. Treatments included TMZ (100 μM), RT (2 Gy), and dactolisib (20 nM).